Semi-automated fact-checking of nucleotide sequence reagents in biomedical research publications: The Seek & Blastn tool

被引:35
作者
Labbe, Cyril [1 ]
Grima, Natalie [2 ]
Gautier, Thierry [3 ]
Favier, Bertrand [4 ]
Byrne, Jennifer A. [2 ,5 ]
机构
[1] Univ Grenoble Alpes, CNRS, Grenoble INP, LIG, Grenoble, France
[2] Childrens Hosp Westmead, Kids Res, Mol Oncol Lab, Childrens Canc Res Unit, Westmead, NSW, Australia
[3] Univ Grenoble Alpes, INSERM, CNRS, U1209,UMR 5309, Grenoble, France
[4] Univ Grenoble Alpes, Etab Francais Sang, Team GREPI, La Tronche, France
[5] Univ Sydney, Fac Med & Hlth, Discipline Child & Adolescent Hlth, Westmead, NSW, Australia
关键词
MINIMUM INFORMATION; GENE; MISCONDUCT; FRAUD; NEED;
D O I
10.1371/journal.pone.0213266
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nucleotide sequence reagents are verifiable experimental reagents in biomedical publications, because their sequence identities can be independently verified and compared with associated text descriptors. We have previously reported that incorrectly identified nucleotide sequence reagents are characteristic of highly similar human gene knockdown studies, some of which have been retracted from the literature on account of possible research fraud. Because of the throughput limitations of manual verification of nucleotide sequences, we developed a semi-automated fact checking tool, Seek & Blastn, to verify the targeting or non-targeting status of published nucleotide sequence reagents. From previously described and unknown corpora of 48 and 155 publications, respectively, Seek & Blastn correctly extracted 304/342 (88.9%) and 1066/1522 (70.0%) nucleotide sequences and a predicted targeting/non-targeting status. Seek & Blastn correctly predicted the targeting/non-targeting status of 293/304 (96.4%) and 988/1066 (92.7%) of the correctly extracted nucleotide sequences. A total of 38/39 (97.4%) or 31/79 (39.2%) Seek & Blastn predictions of incorrect nucleotide sequence reagent use were correct in the two literature corpora. Combined Seek & Blastn and manual analyses identified a list of 91 misidentified nucleotide sequence reagents, which could be built upon through future studies. In summary, incorrect nucleotide sequence reagents represent an under-recognized source of error within the biomedical literature, and fact checking tools such as Seek & Blastn may help to identify papers and manuscripts affected by these errors.
引用
收藏
页数:22
相关论文
共 64 条
[1]  
Acuna D.E., 2018, bioRxiv, DOI [10.1101/269415, DOI 10.1101/269415]
[2]   Experimental data checker: better information for organic chemists [J].
Adams, SE ;
Goodman, JM ;
Kidd, RJ ;
McNaught, AD ;
Murray-Rust, P ;
Norton, FR ;
Townsend, JA ;
Waudby, CA .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (21) :3067-3070
[3]   A tragedy of errors [J].
Allison, David B. ;
Brown, Andrew W. ;
George, Brandon J. ;
Kaiser, Kathryn A. .
NATURE, 2016, 530 (7588) :27-29
[4]  
ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999
[5]   Collective openness and other recommendations for the promotion of research integrity [J].
Anderson, Melissa S. .
SCIENCE AND ENGINEERING ETHICS, 2007, 13 (04) :387-394
[6]   RETRACTION: SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma (Retraction of Vol 10, Pg 2825, 2017) [J].
Huang, W. ;
Huang, H. ;
Wang, L. ;
Hu, J. ;
Song, W. .
ONCOTARGETS AND THERAPY, 2017, 10 :5935-5935
[7]   Downregulation of TPTE2P1 Inhibits Migration and Invasion of Gallbladder Cancer Cells (vol 86, pg 656, 2015) [J].
Lv, Wenjie ;
Wang, Lei ;
Lu, Jianhua ;
Mu, Jiasheng ;
Liu, Yingbin ;
Dong, Ping .
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (04) :1816-1816
[8]   Knockdown of Myosin VI Inhibits Proliferation of Hepatocellular Carcinoma Cells In Vitro (vol 86, pg 723, 2015) [J].
Ma, Xiaoming ;
Yan, Jiqi ;
Chen, Wei ;
Du, Peng ;
Xie, Jiaming ;
Yu, Hongpei ;
Wu, Haorong .
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 92 (04) :1817-1817
[9]  
[Anonymous], 2018, Onco Targets Ther, V11, P7601, DOI 10.2147/OTT.S192186
[10]  
[Anonymous], 2017, Asian Pac J Cancer Prev, V18, P2893